Further details on this would be good:
"As mentioned, Isity Global has a strong pipeline we will be leveraging. Sales gross profit for FY 17 to 19 are strong based on our Due Diligence to date, and will now be subject to formal Independent Experts Review as per ASX requirements.
The first China Project will generate revenue of $20 million per year over a 20-year contract, and I am excited to report that negotiations have been completed for this project and a formal signing ceremony has been scheduled."
Even with a profit margin at 25% on this first contract is equivalent to KKL's current MC after just 1 year. JMHO.
And combined with this:
"We have designed a transaction that we believe is in the best interests of all shareholders and while dilution will occur because of Isity Global meeting their performance targets, they will create significant uplift in shareholder value. Again, Isity does not get additional shares after year 1 unless they meet specific revenue and profitability targets."
- Forums
- ASX - By Stock
- KKL
- Ann: Results of Meeting
Ann: Results of Meeting, page-6
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KKL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online